Chicago Equity Partners LLC Sells 4,845 Shares of Phibro Animal Health Corporation (PAHC)

Chicago Equity Partners LLC trimmed its holdings in Phibro Animal Health Corporation (NASDAQ:PAHC) by 12.7% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 33,415 shares of the company’s stock after selling 4,845 shares during the quarter. Chicago Equity Partners LLC owned 0.17% of Phibro Animal Health Corporation worth $1,238,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Alps Advisors Inc. increased its stake in shares of Phibro Animal Health Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 17,541 shares of the company’s stock worth $650,000 after buying an additional 46 shares during the period. Louisiana State Employees Retirement System increased its stake in shares of Phibro Animal Health Corporation by 1.3% in the second quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock worth $282,000 after buying an additional 100 shares during the period. Arizona State Retirement System increased its stake in shares of Phibro Animal Health Corporation by 1.0% in the second quarter. Arizona State Retirement System now owns 9,800 shares of the company’s stock worth $363,000 after buying an additional 100 shares during the period. Nationwide Fund Advisors increased its stake in shares of Phibro Animal Health Corporation by 1.0% in the second quarter. Nationwide Fund Advisors now owns 10,866 shares of the company’s stock worth $403,000 after buying an additional 110 shares during the period. Finally, Municipal Employees Retirement System of Michigan increased its position in Phibro Animal Health Corporation by 3.6% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after purchasing an additional 150 shares during the period. Hedge funds and other institutional investors own 50.36% of the company’s stock.

A number of research analysts have issued reports on the stock. BidaskClub downgraded shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, August 23rd. Bank of America Corporation reissued an “underperform” rating and set a $33.00 price objective on shares of Phibro Animal Health Corporation in a research report on Wednesday, August 23rd. Piper Jaffray Companies set a $35.00 price objective on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. Credit Suisse Group boosted their price objective on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the company an “outperform” rating in a research report on Thursday, August 31st. Finally, Zacks Investment Research downgraded shares of Phibro Animal Health Corporation from a “buy” rating to a “hold” rating in a research report on Wednesday, November 1st. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. Phibro Animal Health Corporation currently has a consensus rating of “Hold” and a consensus target price of $38.25.

ILLEGAL ACTIVITY WARNING: “Chicago Equity Partners LLC Sells 4,845 Shares of Phibro Animal Health Corporation (PAHC)” was originally reported by Week Herald and is the property of of Week Herald. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://weekherald.com/2017/11/15/chicago-equity-partners-llc-sells-4845-shares-of-phibro-animal-health-corporation-pahc.html.

In other news, VP Daniel M. Bendheim sold 4,976 shares of the business’s stock in a transaction on Monday, August 21st. The shares were sold at an average price of $40.01, for a total transaction of $199,089.76. Following the sale, the vice president now owns 4,176 shares in the company, valued at approximately $167,081.76. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Dean J. Warras sold 10,000 shares of the business’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $35.70, for a total transaction of $357,000.00. Following the sale, the insider now owns 10,000 shares in the company, valued at approximately $357,000. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 284,767 shares of company stock worth $10,317,421. Company insiders own 51.88% of the company’s stock.

Phibro Animal Health Corporation (NASDAQ PAHC) opened at $34.30 on Wednesday. The company has a current ratio of 3.26, a quick ratio of 1.85 and a debt-to-equity ratio of 1.91. The stock has a market cap of $1,384.30, a price-to-earnings ratio of 22.52, a price-to-earnings-growth ratio of 4.04 and a beta of 1.35. Phibro Animal Health Corporation has a 1 year low of $26.10 and a 1 year high of $40.25.

Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its earnings results on Monday, November 6th. The company reported $0.38 EPS for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.01. Phibro Animal Health Corporation had a net margin of 8.87% and a return on equity of 42.75%. The firm had revenue of $193.40 million for the quarter, compared to analysts’ expectations of $189.89 million. During the same quarter in the previous year, the business posted $0.36 EPS. The company’s quarterly revenue was up 2.9% on a year-over-year basis. equities research analysts predict that Phibro Animal Health Corporation will post 1.57 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Wednesday, December 6th will be issued a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date is Tuesday, December 5th. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is presently 23.53%.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC).

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply